Boston Scientific
-
SYN, Devices & Diagnostics, Diagnostics
Some stats on medical device and diagnostics investment/M&A patterns from 2015: Ups and downs
Venture capital went up quite a bit in 2015 reaching $59 billion, more than doubling in the last five years – but according to the latest Silicon Valley Bank report, only $2.4 billion went into medical devices.
-
BSX scores FDA device approval for drug-eluting stent for coronary artery disease patients
Boston Scientific (BSX) received FDA device approval for its Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent […]
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Boston Scientific appoints new investor relations VP
Boston Scientific (BSX) has taken its new investor relations VP from Abiomed (ABMD), the company […]
-
Boston Scientific gets FDA clearance and CE Mark for embolization catheter
Boston Scientific (BSX) received FDA clearance and the CE Mark for its Direxion Torqueable Microcatheter. […]
-
BSX receives CE Mark for deep brain stimulation system as dystonia treatment
Boston Scientific (BSX) announced it has received the CE Mark for its Vercise Deep Brain […]
-
Bet on Medtronic winning the MDT vs. BSX Supreme Court case. Here’s why
The Supreme Court heard oral arguments in Medtronic (MDT) vs. Boston Scientific (BSX) in a […]
-
Two top medical device companies announce promising renal denervation tech results
Two top medical device companies turned up the heat on the renal denervation competition. Both […]
-
BSX scores CE Mark for Lotus Valve System for patients with severe aortic stenosis
Boston Scientific (BSX) announced the medical device company has received a CE Mark for its […]
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Boston Scientific names new CFO for 2014, introduces company restructuring plan
A changing of the guard: Dan Brennan will become Boston Scientific‘s (BSX) new CFO effective […]
-
Devices & Diagnostics, Hospitals, Policy
BSX to pay $30M to end allegations Guidant sold defective defibrillators to Medicare
Guidant continues to prove itself as Boston Scientific’s biggest legal headache. Reuters reports Boston Scientific (BSX) […]
-
Devices & Diagnostics, Startups
FDA grants Neuros Medical IDE approval to conduct clinical trial for pain management technology for amputees
Neuros Medical, a Cleveland-based medical device company, received an FDA investigational device exemption approval to […]
-
Devices & Diagnostics, Hospitals, Startups
Could this device lead to shorter labor and delivery + become childbirth standard of care?
Materna Medical is at work on a device to help protect the more than 80 […]
-
BSX pays out to OrbusNeich to settle stent lawsuit woes
Boston Scientific (BSX) has agreed to make an undisclosed, one-time payment to OrbusNeich to settle […]
-
Devices & Diagnostics, Hospitals, Startups
Will this 2013 Innovation of the Year device change the standard of care for port site closures?
The standard of care for port site closures in laparoscopic surgery may be changing. Irish […]
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
